In medicine, treatment goals set by physicians might differ from patient priorities. Although normalisation of laboratory parameters is a target supported by outcomes data, patient perspectives ...
LFTs are a panel of blood tests that help detect liver injury, cholestasis or synthetic dysfunction. Learn what each marker ...
Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...
Gilead Sciences, Inc. (Nasdaq: GILD) will present new research that reinforces its commitment to advancing innovation for ...
In recent weeks, Gilead Sciences announced Health Canada's conditional approval of LYVDELZI (seladelpar) for primary biliary ...
CNW/ - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Health Canada has approved LYVDELZI (seladelpar) for the ...
Gilead is actively looking for late-stage and de-risked assets for potential deals across various therapeutic spaces, ...
With lifestyle disorders and non-communicable diseases on the rise, many people routinely undergo Liver Function Tests (LFTs) ...
Gilead posts upbeat Q3 results on strong HIV and Livdelzi sales, but shares slip despite earnings and revenue beats.
An update from Genfit SA ( ($GNFT) ) is now available. On October 28, 2025, GENFIT announced its participation in the upcoming AASLD The Liver ...
MedPage Today on MSN
Delaying Gallbladder Removal After Bile Duct Stones May Be Riskier
PHOENIX -- Delaying gallbladder removal after endoscopic retrograde cholangiopancreatography (ERCP) for bile duct stones was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback